The Dual GCGR/GLP-1R Agonist Survodutide Demonstrates Multiple Cardiometabolic Benefits in a Free Choice Diet-Induced Obese Hamster Model (AHA 2026) - Sep 5, 2026 - Abstract #Sa3030; Pres time: Nov 7, 2026; 02:30 PM - 03:30 PM; Location: Population Science Zone‚ Science and Technology Hall‚ South Hall‚ Leve; In-Person; Board no. 3030; No abstract available
Preclinical • Obesity
|
|
Francois Briand; Thomas Klein
|